Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia funds age-related medical R&D:

This article was originally published in Clinica

Executive Summary

Australia has given Aus$7.1m (US$5.1m) for research into cardiovascular disease, especially into atherosclerosis - the commonest cause of death in Australia - to a team at Royal Prince Alfred Hospital and the Hanson Institute, South Australia. The funding, to be released over five years, is part of an Aus$10m initiative to boost research into age-related disease and care. Expressions of interest for the outstanding funds will be accepted until September 2 2005, through the National Health and Medical Research Council (NHMRC) from institutions registered with it. Further information at: www.nhmrc.gov.au

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel